Subscribe
Webinars
White Papers
Buyer's Guide
PhotonicsNXT
Get Published!
Lasers/Sources
Detectors/Imaging
Optics
Bio & Life Sciences
Laser Processing
Test/Measurement
Science & Research
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
LFW Photonics Market Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Atai Life Sciences
Recent news which mentions Atai Life Sciences
Psychedelics 2.0: Companies Explore Safer, More Targeted Therapies
October 04, 2024
Tickers
ATAI
ENVB
NEWS
Tags
Mindstate Design Labs
ATAI
News
From
Benzinga
MDMA Therapy For PTSD Faces FDA Delay: Are There Other Ways Forward?
September 12, 2024
Tickers
ATAI
CMPS
DMT
MBIO
Tags
ATAI Life Sciences
Psychedelics
Health Care
From
Benzinga
Psychedelic Drugs Market Set To Grow By $1.37B By 2028, Driven By Mental Health Disorders And AI Integration
September 05, 2024
Tickers
ABBV
ATAI
CMPS
COMP
Tags
News
MNMD
ATAI
From
Benzinga
Atai's DMT Depression Drug Shows Promise, Prepares For Phase II Trial And Future Collaboration With Pharma Giant
August 14, 2024
Tickers
ATAI
Tags
treatment/resistant depression
Health Care
Psychedelics
From
Benzinga
atai Life Sciences advances VLS-01 for treatment-resistant depression
March 12, 2024
Tags
atai Life Sciences
XNAS:ATAI
From
TheNewswire.com - RSS (Media)
atai's Phase 1 Synthetic DMT-Based Drug Clinical Trial Begins Patient Dosing
October 05, 2022
Tickers
ATAI
Tags
Benzinga
DMT Clinical Trial
Penny Stocks
From
Benzinga
Atai Life Sciences: Capital Raise, Share Options, Cathy Wood And More On Biotech Psychedelics Leader
July 07, 2022
Tickers
ATAI
Tags
ATAI
General
News
From
Benzinga
ATAI Life Sciences Present A "New Recipe For Success" At The Psychedelic Capital Conference
April 29, 2022
Tickers
ATAI
Tags
Psychedelics
Benzinga Psychedelic Capital Conference
ATAI
From
Benzinga
atai Life Sciences Announces Fourth Quarter and Full Year 2021 Financial Results
March 30, 2022
Tickers
ATAI
CMPS
IGXT
Tags
Psychedelics
Small Cap
ATAI Life Sciences
From
Benzinga
Are Psychedelics Starting to Emerge as Legitimate Therapies?
January 19, 2022
Tickers
DMT
MDMA
Tags
AdvisorShares Psychedelics ETF (PSIL)
Doc Gumshoe
Atai Life Sciences
From
Stock Gumshoe
National Institute on Drug Abuse Will Test Ibogaine For Addiction Treatment As Drug Deaths Crest 100,000
December 08, 2021
Tickers
ATAI
NVMDF
Tags
Markets
NVMDF
Regulations
From
Benzinga
New York's Horizons Psychedelic Conference Highlights Big Donations In The Growing Industry
December 07, 2021
Tickers
ATAI
SPCE
TSLA
Tags
Health Care
Small Business
Joe Green
From
Benzinga
Peter Thiel-Backed Psychedelic Start-Up, ATAI Life Sciences, Increases Stake In Compass Pathways
November 29, 2021
Tickers
ATAI
CMPS
Tags
Small Cap
Press Releases
ATAI Life Sciences
From
Benzinga
This Psychedelics Stock Was Up More Than 20% Last Week, Outperforming Tesla, Nvidia and GameStop
November 02, 2021
Tickers
ATAI
GME
NVDA
TSLA
Tags
Binary Options
Biotech
ATAI Life Sciences
From
Benzinga
Journey Clinical raises $3M to allow psychotherapists to prescribe psychedelics
September 17, 2021
Tickers
TC
Tags
Atai Life Sciences
Co/founder
NUE Life Health
From
TechCrunch
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.